CBD: Benefits, Dosage, Forms & Research

What the Research Says

CBD has rapidly growing but still emerging evidence for anxiety and sleep. Shannon et al. (2019) provided the largest clinical observation, but it was a retrospective case series, not an RCT. Linares et al. (2019) provided the strongest RCT evidence for acute anxiety, showing an inverted U-shaped dose response peaking at 300mg. Zuardi et al. (1993) was an early RCT demonstrating CBD's anxiolytic effects in a simulated public speaking test. The sleep evidence is weaker — most studies note sleep improvement as a secondary outcome of anxiety reduction. The main concerns are regulatory inconsistency (CBD product quality varies enormously), significant CYP450 drug interactions, and the limited number of large, well-designed RCTs. The FDA has only approved CBD (as Epidiolex) for specific epilepsy conditions, not for anxiety or sleep.

Benefits of CBD

• Anxiety reduction — Shannon et al. (2019) documented reduced anxiety scores in 79.2% of 72 patients at a psychiatric clinic taking 25-175mg CBD daily, with improvement maintained over the 3-month observation period
• Public speaking anxiety — Linares et al. (2019) conducted a double-blind RCT showing 300mg CBD significantly reduced anxiety during a simulated public speaking test compared to placebo, with an inverted U-shaped dose response (150mg and 600mg were less effective than 300mg)
• Sleep improvement — in the Shannon case series, 66.7% of patients reported improved sleep scores in the first month, though scores fluctuated over time, suggesting CBD's sleep effects may be partly mediated through anxiety reduction
• Serotonin 5-HT1A agonism — Russo et al. (2005) and subsequent research showed CBD acts as an agonist at serotonin 5-HT1A receptors, which are a key target for anxiolytic and antidepressant medications
• Anti-inflammatory neuroprotection — CBD reduces neuroinflammation via CB2 receptor and non-cannabinoid pathways, potentially addressing inflammation-driven sleep and mood disturbances

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

• Fatigue and drowsiness (dose-dependent, common)
• Diarrhea (more common at higher doses)
• Changes in appetite and weight
• Dry mouth
• Liver enzyme elevation at very high doses (Epidiolex studies at 10-20mg/kg/day)
• Drug-drug interactions via CYP450 enzyme inhibition (see interactions)

Drug & Supplement Interactions

• CYP3A4 and CYP2C19 substrates — CBD significantly inhibits these enzymes, affecting metabolism of many medications (statins, calcium channel blockers, etc.)
• Blood thinners (warfarin) — CBD can increase warfarin levels; INR monitoring needed
• Clobazam and other anti-epileptics — CBD increases clobazam levels; relevant for epilepsy patients
• Sedative medications — additive sedation effects
• SSRIs — CBD modulates serotonin; theoretical interaction but generally considered safe at standard doses
• Grapefruit warning drugs — CBD inhibits similar CYP enzymes as grapefruit juice